# Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.

Study · id `cardio:ct-nct04009434` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04009434](<https://clinicaltrials.gov/study/NCT04009434>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04009434

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1162 participants.

## Technical summary

Registry record NCT04009434. Randomized; no masking; primary purpose treatment. Start 2019-12-01 (actual); primary completion 2023-08-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1162 participants (planned count; ClinicalTrials.gov record NCT04009434, source copy `cardio:ctgov-nct04009434-2020-02-05`, retrieved 2026-10-26)
- Started: 2019-12-01 (actual) (ClinicalTrials.gov record NCT04009434, source copy `cardio:ctgov-nct04009434-2020-02-05`, retrieved 2026-10-26)
- Primary completion: 2023-08-01 (anticipated) (ClinicalTrials.gov record NCT04009434, source copy `cardio:ctgov-nct04009434-2020-02-05`, retrieved 2026-10-26)
- Completion: 2023-08-01 (anticipated) (ClinicalTrials.gov record NCT04009434, source copy `cardio:ctgov-nct04009434-2020-02-05`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT04009434, source copy `cardio:ctgov-nct04009434-2020-02-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04009434-2020-02-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.
- Acronym: MITAVI
- Condition: Aortic Stenosis
- Condition: Mitral Regurgitation
- Intervention (Device): Mitral Valve Clipping
- Intervention (Device): TAVI
- Lead sponsor: Technische Universität Dresden
- Lead sponsor class: OTHER
- Collaborator: Zentrum für Klinische Studien Leipzig
- Collaborator class: OTHER
- Collaborator: University Medical Center Mainz
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as a collaborator: University Medical Center Mainz (`cardio:org-university-medical-center-mainz`)

## Provenance

Content hash: f6808af72b6a4b142a4835294566e4e49694f8f6e77b6a2237a684139775b3a0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
